Freenome Stock

Multiomics Platform for Early Disease Screening

Sign up today and learn more about Freenome Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

Founded

2015

Notable Investors

Andreessen Horowitz

Headquarters

South San Francisco CA, US

Total Funding

$77.5M

About Freenome Stock

Headquartered in South San Francisco, Freenome is a health technology company developing accurate, accessible and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages. Freenome aims to reinvent disease management through systematized early detection and intervention. Since launching in 2014, the company has raised more than $70 million from leading technology and healthcare investors.

Investors

Agent Capital

Freenome

Artis Ventures (AV)

Cohesity, Freenome, Cerebral, Artsy

Asset Management Ventures (AMV)

Freenome

Bain Capital Life Sciences

Freenome

BrightEdge Fund

Freenome

Catalio Capital Management

Freenome

Charles River Associates

Freenome

Cormorant Asset Management

Freenome, Bigfoot Biomedical

Farallon Capital Management

Freenome, Genapsys

Janus Henderson Investors

Magic Leap, Freenome, Apartment List

Longevity Vision Fund

Freenome

Loxbridge Research

Freenome

RA Capital Management

Freenome, Somatus

Roche Venture Fund

Freenome, Syapse, Jasper Therapeutics

Rock Springs Capital

Caris Life Sciences, Freenome

Sands Capital Management

Freenome, Biosplice Therapeutics

Soleus Capital

Freenome, Genapsys

Third Kind Venture Capital

Freenome, OfferUp, Hyperscience

Funding History

October 2015$800K
June 2016$5.6M
August 2017$72.0M
June 2019$165M
July 2020$270M

Management

Chief Executive Officer

Mike Nolan

Chief Financial Officer

William Quirk

Press

finsmes - May, 22 2023

Freenome Acquires Oncimmune

massdevice - Jan, 12 2022

Freenome raises $290M from Roche

chinamoneynetwork - Aug, 28 2020

Cancer Screening Startup Freenome Raises $270M

fiercebiotech - Dec, 11 2017

Freenome

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo